Skip to main content
TipRanks
Go Ultimate75% OFF

John Magnani Insider Profile

11 Followers

John Magnani, SVP of Research, CSO at Crescent Biopharma, holds 370.92K shares in Crescent Biopharma (Ticker: CBIO). Most recently, John Magnani Bought 45,045 shares of Crescent Biopharma on Nov 14, 2022 for an estimated value of $52.70K.

John Magnani's Trading History

CBIO
Crescent Biopharma
Nov 14, 2022SVP of Research, CSOInformative Buy52.70K$5.01M
CBIO
Insider Shares: 370.92K (0.71%)
DateTransactionAmountNo. of SharesPrice per ShareProfitLink to Report
Nov 14, 2022Informative Buy$52.70K45,045$1.17-7.50%
Mar 10, 2022Informative Sell$3.52K3,227$1.09-25.00%
Jan 22, 2021Uninformative Buy$0.0034,500$0.00―
Jan 06, 2020Uninformative Buy$119.82K106,983$1.12―
Dec 23, 2019Uninformative Buy$119.82K106,984$1.12―

You May Also Like

John Magnani insider profile FAQ

What is the percentage of profitable transactions made by John Magnani?
The percentage of profitable transactions made by John Magnani is 0%.
What is the average return per transaction made by John Magnani?
The average return per transaction made by John Magnani is -16.20%.
What stocks does John Magnani hold?
John Magnani holds: CBIO stocks.
What was John Magnani’s latest transaction?
John Magnani’s latest transaction was an Informative Buy of $52.70K.
What was John Magnani's most profitable transaction?
John Magnani’s most profitable transaction was an Informative Buy of CBIO stock on November 14, 2022. The return on the trade was -7.50%.
What is John Magnani's role in Crescent Biopharma?
John Magnani's role in Crescent Biopharma is SVP of Research, CSO.
How can I follow the stock ratings of top corporate insiders?
Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.

TipRanks measures corporate insiders by the stock transactions they report to the SEC. See how TipRanks ranks experts and calculates performance.